| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.38 | 0.02 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.43 | 0.02 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.4 | 0.02 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.35 | 0.03 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |